Summaries of the Section H (HML) update

Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.

The table on this page gives a preview of the upcoming changes that will be announced in next month’s Section H of the Pharmaceutical Schedule. 

The changes will be published in the Online HML(external link) around the 23rd of this month and are effective from next month. 

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.

17 December 2024 - preview of changes for January 2025

Pharmaceutical

Change

Amikacin (Biomed) inj 5 mg per ml, 5 ml
syringe

price increase

Amiloride hydrochloride (Biomed) oral liq 1 mg per ml, 25 ml

price increase

Atracurium besylate inj 10 mg per ml, 2.5 ml and 5 ml ampoule 

Brand change

Medsurge – new listing and addition of PSS

  • Inj 10 mg per ml, 2.5 ml ampoule (p’code 2688107)
  • Inj 10 mg per ml, 5 ml ampoule (p’code 2688115) 

Tracrium to be delisted 1 June 2025

Atropine sulphate (Hikma) inj 600 mcg per ml, 1 ml ampoule

new listing (p’code 2693976)

Budesonide with glycopyrronium and eformoterol (Breztri Aerosphere) aerosol inhaler budesonide 160 mcg with glycopyrronium 7.2 mcg and formoterol 5 mcg per dose, 120 dose

new listing (p’code 2656841)

Bupivacaine hydrochloride with fentanyl (Biomed) inj 0.625 mg with fentanyl 2 mcg per ml, 200 ml bag and inj 1.25 mg with fentanyl 2 mcg per ml, 20 ml syringe 

price increase

Caffeine citrate (Biomed) oral liq 20 mg per ml (caffeine 10 mg per ml), 25 ml and inj 20 mg per ml (caffeine 10 mg per ml), 2.5 ml ampoule

price increase

Calcitriol (Calcitriol-AFT) cap 0.25 mcg

new listing (p’code 2695154)

Cetirizine hydrochloride (Histaclear) oral liq 1 mg per ml, 200 ml

price increase

Cetomacrogol (Cetomacrogol Cream AFT) crm BP, 100 g

new listing and addition of PSS (p’code 2696673)

Clomipramine hydrochloride (Clomipramine Teva) cap 10 mg and 25 mg 

price increase

Chlorothiazide (Biomed) oral liq 50 mg per ml, 25 ml

price increase

Cocaine hydrochloride (Biomed) soln 4%, 2 ml syringe

price increase

Covid-19 vaccine (Comirnaty Omicron (JN.1)) inj 3 mcg bretovameran per 0.3 ml, 0.48 ml vial; infant vaccine, yellow cap; inj 10 mcg bretovameran per 0.3 ml, 0.48 ml vial; paediatric vaccine, light blue cap and inj 30 mcg bretovameran per 0.3 ml, 0.48 ml vial; adult vaccine, light grey cap

new listing

  • Inj 3 mcg bretovameran per 0.3 ml, 0.48 ml vial; infant vaccine, yellow cap (p’code 2697378)
  • Inj 10 mcg bretovameran per 0.3 ml, 0.48 ml vial; paediatric vaccine, light blue cap (p’code 2697386)
  • Inj 30 mcg bretovameran per 0.3 ml, 0.48 ml vial; adult vaccine, light grey cap (p’code 2697394)

Covid-19 vaccine (Comirnaty Omicron (XBB.1.5))

  • Inj 3 mcg raxtozinameran per 0.2 ml, 0.4 ml vial; infant vaccine, maroon cap
  • Inj 10 mcg raxtozinameran per 0.3 ml, 0.48 ml vial; paediatric vaccine, light blue cap
  • Inj 30 mcg raxtozinameran per 0.3 ml, 0.48 ml vial; adult vaccine, light grey cap
  • Inj 30 mcg raxtozinameran per 0.3 ml, 2.25 ml vial; adult vaccine, dark grey cap 

to be delisted 1 February 2025

Cyclopentolate hydrochloride (Cyclogyl) eye drops 1%, 15 ml

price increase

Cytarabine (Pfizer) inj 20 mg per ml, 5 ml vial

new Pharmacode listing (p’code 2695758)

Dantrolene (Dantrium) cap 25 mg

new Pharmacode listing (p’code 2648946)

Pharmacode 252409 to be delisted 1 April 2025

Dexamethasone (Biomed) oral liq 1 mg per ml, 25 ml

price increase

Durvalumab (Imfinzi) inj 50 mg per ml, 2.4 ml and 10 ml vial

amended restriction criteria

 

Econazole nitrate (Pevaryl) crm 1%, 20 g

new listing, addition of PSS and
restrictions removed (p’code 2165953)

Eftrenonacog alfa [recombinant factor IX] (Alprolix) inj 250 iu, 500 iu, 1,000 iu, 2,000 iu, 3,000 iu and 4,000 iu vial

new Pharmacode listing

  • Inj 250 iu vial (p’code 2696150)
  • Inj 500 iu vial (p’code 2696169)
  • Inj 1,000 iu vial (p’code 2696177)
  • Inj 2,000 iu vial (p’code 2696185)
  • Inj 3,000 iu vial (p’code 2696193)
  • Inj 4,000 iu vial (p’code 2696207)

Erlotinib (Alchemy) tab 100 mg and 150 mg

amended restriction criteria

Erythromycin (as ethylsuccinate) (E-Mycin) tab 400 mg and grans for oral liq 200 mg and 400 mg per 5 ml, 100 ml

price increase

Flecainide acetate (Tambocor German) inj 10 mg per ml, 15 ml ampoule 

new listing (p’code 2696967)

Fluconazole (Fluconazole-Baxter) inj 2 mg per ml, 50 ml and 100 ml vial 

price increase

Folic acid (Biomed) oral liq 50 mcg per ml, 25 ml

price increase

Gefitinib (Iressa) tab 250 mg

amended restriction criteria

High protein oral feed 2.4 kcal/ml (e.g. Fortisip Compact Protein) liquid 14.6 g protein, 25.3 g carbohydrate and 9.6 g fat per 100 ml, 125 ml bottle

removal of note and delisted date revoked

Hydrocortisone acetate (Colifoam) rectal foam 10%, CFC free (14 applications), 15 g

price increase

Iohexol (Omnipaque) inj 350 mg per ml (iodine equivalent), 75 ml bottle 

to be delisted 1 June 2025

Iron polymaltose (Ferrosig) inj 50 mg per ml, 2 ml ampoule

price increase

Ketamine (Biomed) inj 1 mg per ml, 100 ml bag and inj 10 mg per ml, 10 ml syringe

price increase

Lidocaine [lignocaine] hydrochloride (Lidocaine-Baxter) inj 1%, 5 ml ampoule and 20 ml vial and inj 2%, 5 ml ampoule and 20 ml vial

price increase

Lidocaine [lignocaine] hydrochloride with adrenaline and tetracaine hydrochloride (Topicaine) soln 4% with adrenaline 0.1% and tetracaine hydrochloride 0.5%, 5 ml syringe

price increase

Methylphenidate hydrochloride tab immediate-release 10 mg (Ritalin) and cap modified-release 10 mg, 20 mg, 30 mg and 40 mg
(Ritalin LA)

price increase

Osimertinib (Tagrisso) tab 40 mg and 80 mg 

new listing

· Tab 40 mg (p’code 2536358)

· Tab 80 mg (p’code 2536331)

Palivizumab (Synagis) inj 100 mg per ml, 1 ml vial

new listing (p’code 2621835)

Potassium citrate (Biomed) oral liq 3 mmol per ml, 200 ml

price increase

Promethazine hydrochloride (Phenergan Elixir) oral liq 1 mg per ml, 100 ml 

new listing (p’code 692700)

Risperidone (Risperdal) tab 4 mg

new listing (p’code 245402)

Spironolactone (Biomed) oral liq 5 mg per ml, 25 ml

price increase

Sodium bicarbonate (Biomed) inj 8.4%, 50 ml and 100 ml vial

price increase

Sodium chloride (Biomed) nebuliser soln 7%, 90 ml bottle, 90 ml and inj 23.4% (4 mmol/ml), 20 ml ampoule

price increase

Sodium dihydrogen phosphate [sodium acid phosphate] (Biomed) inj 1 mmol per ml, 20 ml ampoule

price increase

Sodium fusidate [fusidic acid] (Fucithalmic) eye drops 1%, 5 g

new listing (p’code 2697572)

Solifenacin succinate tab 5 mg and 10 mg 

Brand change

Solifenacin succinate Max Health – new listing and addition of PSS

  • Tab 5 mg (p’code 2690608)
  • Tab 10 mg (p’code 2690616)

Solifenacin Viatris to be delisted 1 June 2025

Sucrose (Biomed) oral liq 25%, 25 ml

price increase

Trastuzumab deruxtecan (Enhertu) inj 100 mg per ml, 1 ml vial

new listing (p’code 2678276)

Trastuzumab emtansine (Kadcyla) inj 100 mg and 160 mg vial

amended restriction criteria

 

Tropicamide (Mydriacyl) eye drops 0.5% and 1%, 15 ml

price increase